RESEARCH SUBMISSION REQUIREMENTS
|
|
- Anne Dorsey
- 5 years ago
- Views:
Transcription
1 1. POLICY IRB members rely primarily solely on the documentation submitted by investigators for initial and continuing review. Therefore this material must provide IRB members with enough information about a study to assess whether it adequately meets the IRB s regulatory criteria for approval. A submitted protocol will be scheduled for IRB review when RSPP staff has determined that the information and materials submitted present an adequate description of the proposed research or action. Specific Policies Terms used in this policy, but not defined herein shall have the meanings set forth in the Glossary Submission Requirements for Initial Review Submissions to the IRB are accepted in two formats: paper Microsoft Word/PDF (via ) or the Cyber IRB electronic method. Both formats require that the same documents be included with the submission. The difference between submission formats is in the number of copies that must be included with the submission, and the need for the whether an original or electronic signature on an applicable document is acceptable. Cyber IRB will allow any and all required documents to be uploaded electronically in a web-based system. with the submission application.the submission application is completed online. It and all uploaded documents are made available to the RSPP office electronically. The Cyber IRB format requires that the PI provide an electronic signature for submission. Cyber IRB is 21 CFR part 11 compliant which allows for electronic signature of documents. The Microsoft Word/PDF format requires that all submission documents (submission form and others) be sent to the IRB office as Microsoft Word or PDF files (depending on the document type). This can be accomplished by attaching all documents to an sent to the RSPP office. The Word/PDF format requires the PI to sign the submission form prior to sending to the IRB office as a scanned document (PDF) Required: Initial applications must include: Steering Committee approved / effective date: 2/2511 Clearance from Aurora s Senior Vice President of Research (or designee) to conduct the human subject research project.
2 IRB Submission Application (Form FO 301-A or FO 302-A) in sufficient detail to allow the IRB to ascertain that a study meets the regulatory criteria for approval. Applications completed in the paper-based system format, must be signed by the Principal Investigator and the original signature must be on file in the RSPP office. For Cyber IRB submissions, electronic signature is acceptable as Cyber IRB is 21 CFR part 11 compliant. If applicable, the complete Rresearch protocol from the sponsor indicating that includes version date or tracking informationor revision numbers PROTOCOL template (including sponsor s ssample informed consent document). If applicable, the Investigator Brochure (investigational drug or biologic), Package Insert (approved drug) or Device Operator Manual /Instructions for Use or device specifications and that includes the version date or tracking information of such brochure or manual. If applicable, any data collection tools, surveys, questionnaires, assessment instruments, and case report forms to be used. If applicable, proposed local informed consent/authorization document containing all required elements required by federal regulationsof informed consent, as well asand those additional elements as when appropriate, using the Aurora IRB-approved template as a guide. All materials to be received or reviewed by subjects (e.g., diaries, blister packs, instruction sheets, videos). Any proposed recruitment materials (e.g., advertisements, letters, phone scripts, Dear Doctor letters, etc.) to be used. (See also Policy RR 406). If the study is federally funded, and Aurora is the funding recipient (i.e. the awardee ) of the grantan the awardee, a copy of the grant/ proposal (including the budget pages DO WE NEED BUDGET?? but without the appendices) must be submitted for reviewto the RSPP office. A copy of the grant application/ or proposal will be retained by the RSPP Office in the study file. The Primary reviewer and the IRB will review the grant/proposal, and the
3 meeting minutes will document such reviewand made available to any IRB member who may wish to review it. The grant application/proposal will be reviewed by the Primary Reviewer in accordance with OHRP guidance by the Primary Reviewer. Copy of the Principal Investigator s current CV or other supporting material evidencing clinical privilegesshowing sufficient expertise necessary to conduct proposed research study. Conflict of Interest Statement (GA 104-A) signed by each investigator and key personnel listed on the submission application. Applications completed in the paper format must include an original signature on each COI form. The original form for each investigator will be kept on file in RSPP office. Applications completed in Cyber IRB do not require an original signature on the COI form. A scanned copy of the signed form may be uploaded with the Cyber IRB submission application. [Note that COI forms are not required for studies that qualify for exemption from IRB review (see policy FO 302)]. Delegation of Authority log (RR 402-C). Note: Prior to submission to the Aurora IRB, Aall investigators and key personnel listed on the submission application are required to have completed a current interest disclosure statement in COI Smart as required by AHC system policy #269. They are also required to hold Research Certificationcomplete the training requirements found in hold Research Certification (policy GA 102) (section 1.1) prior to issuance of the final approval letter. The Principal Investigator must have completed the Research Certification process prior to the submitting the protocol for review In addition, the following items are required if when applicable: Delegation of Authority log. The DHHS-approved sample consent document (when one exists). The ccomplete DHHS-approved protocol. (when one exists). Copy of the signed FDA Form 1571, 1572 (IND) or signed Investigator Agreement (IDE).
4 If the study involves a Significant Risk device, Investigation Device Exemption (IDE), a copy of FDA s Investigational Device Exemption (IDE) letter giving clearance to begin the study. If the study involves an unapproved drug or a drug being studied for a new indication investigational drug (i.e. an IND number has been assigned the study drug), the IND number should be printed on the sponsor protocol. If not, and the IND number is not stated in the sponsor s protocol, a copy of the FDA s acknowledgment letter noting the IND number issued assigned to the drugprotocol, OR a letter from the sponsor stating that the IND number provided on the submission application form is the correct IND number for the drug being investigated in and the study protocol under review must be provided. If the protocol meets the criteria for an IND exemption, the sponsor must provide the IND Exemption letter from the FDA, or justification regarding the IND Exemption for IRB concurrence. ation that the study has been reviewed and approved by other appropriate committees/entities (such as Radiation Safety, Institutional Biosafety Committee, etc.) IRB fform SC 502A (see Policy SOP SC 502) for Preparatory to Research Activities or to when requesting a wwaiver of HIPAA authorization. Applications completed in the paper format must include an an the original signature by of the Principal Investigator. The original form will be filed in RSPP office. Applications completed in Cyber IRB do not require an original signature. A scanned copy of the signed form may be uploaded with the Cyber IRB submission application. Any investigator who does not meet the definition of Affiliated with Aurora set forth in section of Policy SC 502, must have the support and assistance of a Facilitator (see section 1.5 below) who is Affiliated with Aurora, prior to submitting a research request or other related activity to the IRB Requirements for Ongoing Monitoring of IRB Approved Research During the approval period, the IRB is required to conduct ongoing monitoring of the research study (see Policy SOP RR 403). Investigators must promptly submit documentation to inform the IRB about problems, issues, new information, and study status changes in the status of the study including, but not necessarily limited to the following, as noted in SOP 403:
5 Significant protocol violations; (as defined in Policy RR 403) must be reported to the IRB on Form RR 403-G.; Reports of Unanticipated Problems, as defined in Policy RR 403, must be reported to the IRB on Forms RR 403-A or RR 403-B, as applicable;. Significant new findings (DSMB reports, annual reports, updates to investigator brochures, etc.) must be reported to the IRB on Form RR 403-F.; Amendments and/or changes to the research study (including temporary holds on enrollment or enrollment closures), protocol or informed consent document must be reported to the IRB using the IRB Modification form (Form RR 403-C);. Investigators must obtain IRB approval before undertaking any change to the approved protocol, except where necessary to eliminate apparent immediate hazards to human subjects. Notification that a study has been completed and the IRB file may be permanently closed must be reported to the IRB using the Continuing Review Report/Final Report Form (Form RR 404-ASee SOP 404) Continuing Review Report to Request Renewal of IRB Approval. Renewal of IRB approval of the study must be done at least annually per SOP 404 utilizing the Continued Review Report/Final Report Form (RR 404-A). The IRB office will notify the investigator that continuing review is due in accordance with Policy RR-404. Investigators must submit: A completed Continuing Review Report/Final Report Form (Form RR 404-A). All the required materials as indicated on the form Action Taken If ation is Not Adequate or Additional Information is Required If the IRB, IRB Chair, or RSPP staff Director/Staff determine that the submitted documents are not adequate, Investigators may will be required to submit additional information, or the study may be returned to them for revisions. No incomplete submission will be reviewed by the IRB.
6 The presence of the Investigator (or his/her representative) is recommendedmay be requested at the IRB meeting in order for him/her to answer address any questions by the IRB or explain the details of the study Access to RSPP Study File Materials Access to the study file contents will be limited to the IRB members, RSPP staff, and others as determined appropriate by the RSPP Manager Director (e.g., study staff, ARI Quality review staff, representatives from regulatory agencies and accrediting agencies, etc.). Each individual who accesses the RSPP study file must complete the Access Log (FO 301-C). Individual requests must be made to the IRB office in advance. The RSPP Manager Director will determine whether access to the files is allowed Research Facilitator Any individual who is not Affiliated with Aurora that is, he/she is not an employee, a member of the medical staff or an allied health professional on the medical staff, of an Aurora Facility or a hospital, clinic, physician group or other entity that has entered an affiliation agreement with an Aurora Facility must have the support and assistance of a Facilitator prior to submitting a project for review by the Aurora IRB. The submission form has a place to document the name and signature of agreement of the designated Facilitator Facilitator Credentials Aurora Health Care employees or physicians on the medical staff or an allied health profession on the medical staff of any Aurora hospital Facility may serve as an Aurora research facilitator, if they meet the following requirements: a certificate of completion for the NIH tutorial is on file with the Aurora RSPP office hold Research Certification (see SOP GA 102); obtain their manager s approval (if applicable); are familiarity with Aurora IRB policies and guidelines; and be a physician or doctoral level scientist, or have a master s degree Facilitator Responsibilities The research facilitator will:
7 direct the investigator (who does not meet the definition of Affiliated with Aurora ) to appropriate managers or administrators to seek administrative approval (e.g. clinical units, Clinical Research Department, Radiology Department, etc.) and contractual agreements (if applicable) for the study (e.g. clinical units, Clinical Research Department, Radiology Department, etc.); direct the investigator to appropriate Aurora IRB policies related to research conduct and to other system-wide policies applicable to research; facilitate integration of the research into the clinical operations of the appropriate units or propose additional budgeting to subcontract study management outside of the Aurora clinical staff s workload (e.g. possibly with the Clinical Research Department, CV Research Department, or Imaging Research Departmentvia Aurora Research Institute); and review the entire submission packet and sign the final version of the Aurora IRB submission form. 2. SCOPE These policies and procedures apply to all research submitted to the IRB. 3. APPLICABLE REGULATIONS, GUIDELINES AND STANDARDS 45 CFR CFR (a)(4) 21 CFR 312, 812 ICH Good Clinical Practice (GCP) Guideline AAHRPP Elements II.2.D., II.2.E., and II.3.C REFERENCES TO OTHER APPLICABLE SOPS This SOP affects all other SOPs.
IRB MEETING ADMINISTRATION
1. POLICY Steering Committee approved / Effective date: 9/11/15 Except when an expedited review procedure is appropriate or an exemption determination may be made, the IRB will review proposed research
More informationSupersedes Document Dated: 7/7/11. SOP: RR 401 Version No.: 07 Version Date: 9/8/15 EXPEDITED REVIEW 1. POLICY
1. POLICY Steering Committee approved / Effective Date: 9/9/15 An expedited review procedure consists of a review of research involving human subjects by an IRB Chair or by one or more experienced reviewers
More informationIRB MEETING ADMINISTRATION
1. POLICY Steering Committee approved / eeffective date: 8/31/15 4/6/11 Except when an expedited review procedure is used appropriate or an exemption determination may be madea study is deemed exempt,
More informationEXPEDITED REVIEW. Terms used in this policy, but not defined herein shall have the meanings set forth in the Glossary.
1. POLICY Steering Committee approved / Effective Date: 9/19/11 An expedited review procedure consists of a review of research involving human subjects by an IRB Chair or by one or more experienced reviewers
More informationUniversity of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP)
University of Iowa External/Central IRB Reliance Process Standard Operating Procedure (SOP) I. OVERVIEW The purpose of this Standard Operating Procedure is to define a process for all University of Iowa
More informationSOP 801: Investigator Qualifications and Responsibilities
1. POLICY University of Oklahoma : Investigator Qualifications and Responsibilities The purpose of this policy is to outline the qualifications and responsibilities of the principal investigator and key
More informationCONTINUING REVIEW CRITERIA FOR RENEWAL
1. POLICY Steering Committee approved / Effective Date: 9/2/15 The IRB conducts continuing review of research taking place within its jurisdiction at intervals appropriate to the degree of risk, but not
More informationEffective Date: January 16, 2012 Policy Number: MHC_RP0107. Revised Date: November 2, 2015 Oversight Level: Corporate
Policy Title: Initial Review of Human Subject Research Effective Date: January 16, 2012 Policy Number: Review Date: November 20, 2015 Section: Revised Date: November 2, 2015 Oversight Level: Corporate
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW AND REAPPROVAL OF RESEARCH I. PURPOSE This document outlines the required elements of University of Tennessee
More informationStudy Management SM STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB)
Study Management SM 302.00 STANDARD OPERATING PROCEDURE FOR Interactions with the Institutional Review Board (IRB) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval:
More informationUNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW
UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE INSTITUTIONAL REVIEW BOARD PROCEDURES FOR FULL BOARD REVIEW I. PURPOSE This document outlines the required elements of Institutional Review Board (IRB)
More informationInitial Review. Approved By: Michele Kennett, JD, MSN, LLM Associate Vice Chancellor for Research. Table of Contents
Institutional Review Board University of Missouri-Columbia Standard Operating Procedure Initial Review Initial Review Effective Date: September 1, 2004 Original Approval Date: September 1, 2004 Revision
More informationCONTINUING REVIEW CRITERIA FOR RENEWAL
1. POLICY Steering Committee approved / Effective Date: 9/2/19/19/11 The IRB conducts continuing review of research taking place within its jurisdiction at intervals appropriate to the degree of risk,
More informationThe Children s Hospital of Philadelphia Committee for the Protection of Human Subjects Policies and Procedures. Cooperative Agreements
Page: 1 of 8 I. PURPOSE This standard operating procedure describes the IRB s procedures for review and oversight of research conducted under a cooperative agreement with an external (outside) IRB. It
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Penn as Central IRB FAQ
Reliance Agreement Guidance: Penn as Central IRB FAQ This document is designed to answer questions frequently asked by individuals who want to know more about Penn s policies and procedures related to
More informationScreening and Enrollment Log. List of all subjects screened and all subjects screened and enrolled in the study.
Contents Screening and Enrollment Log... 2 Regulatory Approval... 3 Protocol, Amendments and Signature Pages... 4 Investigational Product Information - 1... 5 Investigational Product Information - 2...
More informationI. Summary. II. Responsibilities
IRB Procedures 9a: Full review procedures Revision date: October 6, 2008, revision November 11, 2009, revision July 17, 2010, revised January 27, 2011, revised February 9, 2015, revised October 15, 2015
More informationUNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH
UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER INSTITUTIONAL REVIEW BOARD CONTINUING REVIEW OF RESEARCH I. PURPOSE This document outlines the University of Tennessee Health Science Center Institutional
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures Continuing Review of Approved Research
Page: 1 of 6 I. PURPOSE The purpose of this SOP is to describe the submission requirements for investigators and the review requirements for the IRB for the conduct of continuing review in accordance with
More informationInvestigator Manual. If you have questions about whether an activity requires IRB review, contact the IRB Office.
CM-999 001 1 May 2015 Page 1 of 5 What is the purpose of this manual? This document is designed to guide you through policies and procedures related to the conduct of human research that are specific to
More informationI. Summary. II. Responsibilities
IRB Procedure 11a: Continuing Review Revision Date: May 15, 2007, revised November 11, 2009, revision July 17, 2010, revised March 1, 2011, revised February 9, 2015 I. Summary The IRB policy is to make
More informationChapter 4 Institutional Review Board (IRB) Roles and Authorities
Chapter 4 Institutional Review Board (IRB) Roles and Authorities HSS Institutional Review Board Guidance An Institutional Review Board (IRB) is an appropriately constituted group that has been formally
More information7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL
7.0 DEVIATION and EXCEPTION of a PREVIOUSLY APPROVED PROTOCOL 7.1 OBJECTIVE To describe the policies and procedures for reviewing a modification or a deviation/exception to a previously approved protocol.
More informationHuman Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital
Human Research Protections Program Medical College of Wisconsin and Froedtert Memorial Lutheran Hospital To Whom It May Concern: The Medical College of Wisconsin (MCW) has an approved Federal Wide Assurance
More informationSUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH
P&P: RR 409 Version No:1.2 Effective Date: 11/20/2013 SUSPENSION OR TERMINATION OF HUMAN SUBJECTS RESEARCH Supercedes: CPHS Policies and Procedures 11/28/2000 1. POLICY The IRB shall have authority to
More informationUNIVERSITY OF GEORGIA Institutional Review Board
UNIVERSITY OF GEORGIA Institutional Review Board Continuing Review Number: Date: Author: Approved By: Page(s): UGAHRP-057-2 01/20/2017 HSO IRB Page 1 of 7 1. PURPOSE 1.1. The UGA IRB has developed this
More informationReview of Research by the Convened IRB
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 Review of Research by the Convened IRB 201 AOB (MC 672) 1737 West Polk Street Chicago, IL 60612-7227 Phone:
More informationSignature Date Date First Effective: Signature Date Revision Date:
Revision #10 TITLE: Continuation Review Page 1 of 10 Approved By: ORI Director Signature Date Date First Effective: 05-17-05 Approved By: Nonmedical IRB Chair Signature Date Approved By: Medical IRB Chair
More informationBaptist Health Institutional Review Board. Study Closure Report (Expedited Review) IRB #: Study Title:
Baptist Health Institutional Review Board Study Closure Report (Expedited Review) (Please complete ALL sections of this form. Incomplete forms will be returned) Principal Investigator: E-mail: Phone #:
More informationSOP 5.06 Full Committee Review: Initial IRB Review
Office of Research Integrity - Human Subjects SOP #: ORI-HS(HS)- Page #: Page 1 of 5 Approved By: ORI-HS Executive Director *Signature on file Date: Date First Effective: 10/13/2016 Approved by: Biomedical
More informationReporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB
INSTITUTIONAL REVIEW BOARD (IRB) OFFICE FOR HUMAN RESEARCH PROTECTION Reporting an Unanticipated Problem Involving Risks to Subjects or Others (UPIRTSO) to the IRB UPIRTSO Flowchart Content Applies To
More informationStandard Operating Policy and Procedures (SOPP) 3:
Standard Operating Policy and Procedures (SOPP) 3: INITIAL AND CONTINUING REVIEW BY THE IRB: REQUIREMENTS FOR SUBMISSION OF APPLICATIONS, APPROVAL CRITERIA, EXPEDITED AND CONVENED COMMITTEE REVIEW AND
More informationSOP #2-2 Version #1 Date First Effective: December 14, Page 1 of 6
Page 1 of 6 OBJECTIVE To describe policies and procedures for all types of protocol submissions that require review by the IRB after investigators receive initial approval. This includes protocol submissions
More informationFlorida State University IRB Standard Operational Procedures
Florida State University IRB Standard Operational Procedures 7-IRB-12 Title of Standard Operational Procedure: Cooperative Project/Multi-site projects IRB Review Responsible Executive: Approving Official:
More informationYour Roadmap to Single IRB Review Serving as a Reviewing IRB
Your Roadmap to Single IRB Review Serving as a Reviewing IRB Funded by the NIH Clinical and Translational Science Awards (CTSA) Program, grant number 3 UL1 TR002541-01S1 Nichelle Cobb, PhD Director, Health
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: How to Apply for External IRB Review
Reliance Agreement Guidance: How to Apply for External IRB Review This document provides step by step instructions on how to submit a request for the Penn IRB to rely on an External IRB using the HS-ERA
More informationTo assure knowledge and compliance by documenting the annual administrative review and continuing IRB review of non-exempt projects for the IRB.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Annual Review of Research Annual Review of Research Effective Date: January 21, 2019 Original Approval Date:
More informationCommercial/ Central IRB An independent organization that provides IRB review services
Page 1 of 12 Reliant Review Research Conducted at Multiple Sites Introduction: Reliant Review engages reliance agreements to reduce duplicative IRB reviews, aiming to promote greater efficiency and consistency
More informationSignature Date Date First Effective: Signature Date Revision Date: 07/18/2011
University of Kentucky Office of Research Integrity and Institutional Review Board Revision #4 TITLE: HIPAA in Research Page 1 of 8 Approved By: ORI Director Signature Date Date First Effective: 06-10-05
More informationAdministrative Hold, Suspension, or Termination of IRB Approval
Office for the Protection of Research Subjects (OPRS) Institutional Review Board FWA# 00000083 Administrative Hold, Suspension, or Termination of IRB Approval 201 AOB (MC 672) 1737 West Polk Street Chicago,
More informationSignature Date Date First Effective: Signature Date Revision Date: 05/14/2014
Page 1 of 6 Approved By: ORI Director Signature Date Date First Effective: 06-28-05 Approved By: Nonmedical IRB Chair Signature Date Approved By: Medical IRB Chair Signature Date Revision Date: 05/14/2014
More informationCollaborative Research
University of Hawai i HRPP Standard Operating Procedures Purpose and Scope Collaborative Research SOP 120.2 Revised: December 18, 2015 This document covers procedures for establishing IRB coverage of collaborative
More information2 Institutional Review Board
2 Institutional Review Board 2.1 Policy The University has established two Institutional Review Boards ( IRBs ) to ensure the protection of Human Subjects in Research Under the Auspices of the Institution.
More informationTuesday, May 15, Please be sure to sign in and take copies of each handout.
Tuesday, May 15, 2012 Please be sure to sign in and take copies of each handout. 1 Michelle Dolske, ORA 2 Laura Orem, IRB Must be in list of Categories (see IRBNet Forms and Templates) No more than minimal
More informationIRB Chair Responsibilities
IRB Chair Responsibilities Introduction: The Saint Luke s Health System (SLHS) Institutional Review Board (IRB) Human Research Protection Program (HRPP) is guided by the ethical principles regarding research
More informationSOP 407: PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS
University of Oklahoma Office of Human Research Participant Protection : PROTOCOL DEVIATIONS AND UNANTICIPATED PROBLEMS 1. POLICY Protocol deviations and unanticipated problems may be discovered in a variety
More informationCONTINUING REVIEW 3/7/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program Introduction CONTINUING REVIEW 3/7/2016 Federal regulations require that DUHS has written procedures which the IRB will follow for (a) conducting
More informationA Guide to SMART IRB s Resources for IRB and HRPP Personnel
Your Roadmap to Single IRB Review A Guide to SMART IRB s Resources for IRB and HRPP Personnel Nichelle Cobb, PhD Health Sciences IRBs Office Director University of Wisconsin-Madison & Chief Regulatory
More informationIRB-REQUIRED INVESTIGATOR ACTIONS
Version No: 2 Effective Date: 11/01/02 Revised: 06/10/2005 09/08, 05/2009 1. POLICY IRB-REQUIRED INVESTIGATOR ACTIONS SOP: RI 801 Page 1 of 4 Between IRB initial approval of a protocol and the time of
More informationChildren s Hospital of Philadelphia Committees for the Protection of Human Subjects Policies and Procedures. IRB Review Processes
Page: 1 of 8 I. PURPOSE II. III. IV. The purpose of this standard operating procedure is to describe IRB review processes, including pre-review, review, and post-review procedures. POLICY STATEMENT The
More informationInfo Sheet - Operations Office for Human Research Studies
Guidance on Single IRB Review Process This document outlines how the DFCI IRB may rely on an external IRB to serve as the IRB of record for a DF/HCC site or Investigator. The Dana-Farber Cancer Institute
More informationCeded IRB Review. The University of Arizona has standing agreements in place for the following entities regarding ceded IRB review:
Investigators working at multiple institutions and with multiple IRBs may choose to have one IRB become the IRB of record over some or all participating sites (commonly referred to as ceded review, reliance
More informationInstitutional Review Board Standard Operating Procedure. Suspension and Termination of IRB Approval
Institutional Review Board Standard Operating Procedure University of Missouri-Columbia Suspension and Termination of IRB Approval Effective Date: May 31, 2006 Original Approval Date: May 31, 2006 Revision
More informationVersion 1. Submission Guide and Policies
Submission Guide and Policies Pearl IRB Investigator Manual Table of Contents 1.1 Pearl IRB overview... 3 1.2 What is the purpose of this manual?... 3 1.3 What is Human Research?... 3 1.4 What is the Human
More informationUniversity of Pennsylvania Institutional Review Board. Reliance Agreement Guidance: Post-Approval Submissions
Reliance Agreement Guidance: Post-Approval Submissions This document is designed to provide guidance on the requirements and submission processes for Amendments, Continuing Review, Reportable Events, and
More informationResearch Involving Human Subjects: AA 110.7
Research Involving Human Subjects: AA 110.7 Purpose To set forth certain human subjects rights and protections, and to establish a review process intended to ensure compliance with federal regulations
More informationSMART IRB Agreement Implementation Checklist and Documentation Tool
SMART IRB Agreement Implementation Checklist and Documentation Tool Purpose: (1) to highlight the flexible provisions of the SMART IRB Agreement, and (2) to document which options institutions will implement
More informationIndependent Ethics Committees
GCP Independent Ethics Committees 1 GCP What is an Ethics Committee? An ethics committee is a committee formally designated to review and approve the initiation of a clinical research study involving human
More informationWhat s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies
Vol. 8, No. 8, August 2012 Happy Trials to You What s New in GCP? FDA, OHRP Issue Harmonized Guidance on Transferring IRB Oversight of Clinical Studies Reprinted from the Guide to Good Clinical Practice
More informationAMENDMENTS TO PREVIOUSLY APPROVED RESEARCH 3/01/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program AMENDMENTS TO PREVIOUSLY APPROVED RESEARCH 3/01/2016 The Duke University Health System Institutional Review Board (DUHS IRB) requires that
More informationWayne State University Institutional Review Board
Wayne State University Institutional Review Board Subject Approvals, Serious & Continuing Non-Compliance and the Institutional Official s Responsibilities Administrative Approval: 07/2011; Office of the
More informationUniversity of Iowa External/Central IRB Single IRB (sirb) Reliance Process Standard Operating Procedure (SOP)
University of Iowa External/Central IRB Single IRB (sirb) Reliance Process Standard Operating Procedure (SOP) I. OVERVIEW The purpose of this Standard Operating Procedures document is to define outline
More informationCOMPLIANCE MONITORING
In this chapter: 3.1 Policies, Procedures, and Resources Available to Investigators and Research Staff 3.2 Investigators Conflicts of Interest (COI) -Individual Conflict of Interest Policies -Disclosure
More informationNIH StrokeNet Network Standard Operating Procedure
1. POLICY This policy will define the recommended process for the addition of new satellite sites. The Principal Investigator (PI) of the Regional Coordinating Center (RCC) ultimately has decision making
More informationCONTINUING REVIEW OF APPROVED IRB PROTOCOLS
POLICY # RESEARCH POLICY & PROCEDURE Approval Date: 4-13-2012 CTM c Review Cycle: 1 2 3 Revision Dates: AAHRPP DOC # 64 Responsible Office: CONTINUING REVIEW OF APPROVED IRB PROTOCOLS Research Compliance
More informationHEALTH CARE SYSTEMS RESEARCH NETWORK
IRB APPROVAL OF HCSRN MULTI-SITE RESEARCH: FREQUENTLY ASKED QUESTIONS (AND ANSWERS) The goal of SOP HCSRN-001,, is to make human subjects review as efficient and timely as possible, while still recognizing
More informationYale University Institutional Review Boards
Yale University Institutional Review Boards 100 PR.1 Review by a Convened Institutional Review Board (IRB) Overview... 1 Meeting Dates and Distribution of Materials... 1 Materials Provided to Members for
More informationSOP Title Review of Research: Devices for Humanitarian Uses
SOP Title Review of Research: Devices for Humanitarian Uses Purpose This document describes the National Jewish Health IRB review of Humanitarian Use Devices and Humanitarian Device Exemptions. Scope Humanitarian
More informationINTRA-INSTITUTIONAL COMMUNICATION
P&P: CO 602 Version No: 1.1 Effective Date: 10/1/2009 1. POLICY INTRA-INSTITUTIONAL COMMUNICATION Supercedes: CPHS Policies and Procedures 11/1/2007 The efficiency and effectiveness of the IRB is supported
More informationRESEARCH PROTECTIONS OFFICE
Page 1 of 5 RESEARCH PROTECTIONS OFFICE Single IRB RPO Human Subjects Research Single IRB Single IRB Definitions Authorization Agreement/Reliance Agreement written agreement between two or more institutions
More informationSYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES 02 06/30/10 08/01/07 1 OF 6
TITLE: IRB CONTINUING REVIEW REVISION NUMBER SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES REVISION DATE (SUPERSEDES PRIOR VERSION) EFFECTIVE DATE DOCUMENT NUMBER:
More informationOHRP Guidance on Written IRB Procedures
Office for Human Research Protections (OHRP) Department of Health and Human Services Date: OHRP Guidance on Written IRB Procedures Scope: This document outlines the required elements of written Institutional
More informationSubmitting Continuing Reviews and/or Amendments to the IRB
Submitting Continuing Reviews and/or Amendments to the IRB Tufts-New England Medical Center Tufts University Health Sciences IRB Education Series 2006 Presentation may only be reused or reprinted with
More informationPRINCIPAL INVESTIGATOR S ACKNOWLEDGMENT OF RESPONSIBILITIES
PRINCIPAL INVESTIGATOR S ACKNOWLEDGMENT OF RESPONSIBILITIES The Principal Investigator is responsible for ensuring that an investigation is conducted according to the signed investigator statement, the
More informationSingle IRB Review. Jeannie Barone Director, HRPO. Institutional Review Board
Single IRB Review Jeannie Barone Director, HRPO Presentation Agenda New NIH policy Requests for Single IRB review Investigator vs. institutional responsibilities Current Regulations 45 CFR 46.111 (DHHS):
More informationCeded IRB Review. The project involves prisoners or other vulnerable populations that require special considerations.
The first assessment to make when including collaborators in research is whether the collaborating entity is engaged in research (see OHRP s Guidance on Engagement in Research). IRB oversight of engaged
More informationIRB Authorization Agreement Implementation Checklist and Documentation Tool
IRB Authorization Agreement Implementation Checklist and Documentation Tool This is the preferred selections version. If more flexible terms are needed, download the blank version from the IRB website.
More informationTitle: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH
SYRACUSE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM STANDARD OPERATING PROCEDURES TITLE: EXPEDITED IRB REVIEW OF HUMAN SUBJECTS RESEARCH DOCUMENT NUMBER: 012 REVISION NUMBER REVISION DATE (SUPERSEDES
More informationDOCUMENTATION OF IRB DISCUSSIONS AND DECISIONS ( IRB MINUTES)
POLICY # RESEARCH POLICY & PROCEDURE Approval Date: 12-19-2008 CTM Review Cycle: 1 2 3 Revision Dates: AAHRPP DOC # 54 Responsible Office: Research Compliance DOCUMENTATION OF IRB DISCUSSIONS AND DECISIONS
More informationNovember 30, Efficient Startup of Multi-site Research Studies: Central IRBs and National IRB Reliance Platforms
November 30, 2017 Efficient Startup of Multi-site Research Studies: Central IRBs and National IRB Reliance Platforms Agenda Working with a Central IRB SMART IRB IRBchoice Single IRB vs. Central IRB They
More informationMichigan State University Human Research Protection Program
Subject: Noncompliance Section: 9-2 Michigan State University Human Research Protection Program This policy and procedure supersedes those previously drafted. Approved by: Vice President of Research and
More informationUSC Institutional Review Boards (IRBs)
Chapter 6: Chapter Contents 6.1 Description of USC IRBs USC Institutional Review Boards (IRBs) 6.2 The Membership of the IRB Committees 6.3 IRB Member Requirements 6.4 IRB Use of Consultants 6.5 IRB Support
More informationUniversity of Cincinnati. Radiation Safety Committee Operations Guidelines Statement of Policy (RSC Guidelines) RSC Guidelines (revision 5)
University of Cincinnati Radiation Safety Committee Operations Guidelines Statement of Policy (RSC Guidelines) Table of Contents 1 Purpose of the Guidelines 1 2 Committee 1 3 Meetings 4 4 Committee Purpose,
More informationTo assure knowledge and compliance by documenting the continuing review procedure of approved projects for the IRB.
Institutional Review Board.... University of Missouri-Columbia.. Standard Operating Procedure Continuing Review Report (CRR) Continuing Review Report (CRR) Effective Date: July 1, 2004 Original Approval
More informationDate Effective 4/21/2008 Identification
OHSU Research Integrity Office Human Research Protection Program Policies & Procedures Title: Research with Medical Devices Date Effective 4/21/2008 Identification Supersedes P&P dated: Page 1 of BACKGROUND
More informationCentralized IRB Models
Centralized IRB Models NWABR / OHRP Conference July 31, 2014 James Riddle, MCSE, CIP, CPIA Assistant Director, Institutional Review Office Fred Hutchinson Cancer Research Center Outline Central IRB s Why
More informationThis policy defines the composition and requirements of the North Shore Medical Center (NSMC) Institutional Review Board (IRB) membership.
THE NORTH SHORE MEDICAL CENTER Institutional Review Board (IRB) POLICIES AND PROCEDURES Title: IRB Composition and Roster Page: 1 of 6 Written by: Laura W. Knight, MPH; Sr. IRB Administrator IRB Policy
More informationYour Roadmap to Single IRB Review Getting Started with SMART IRB & the Online Reliance System
Your Roadmap to Single IRB Review Getting Started with SMART IRB & the Online Reliance System Now that your institution has joined SMART IRB, what s next? Start using the Agreement right away for IRB reliance
More information2.0 Institutional Review Board
2.0 Institutional Review Board 2.1 Policy Pennington Biomedical Research Center has one IRB to ensure the protection of human subjects in research. IRB Biomedical (IRB 00000708) (IORG00006218) The IRB
More information1. Review and approval of the consent document is a responsibility that FDA assigns to the IRB with jurisdiction
Medical College of Wisconsin/Froedtert Hospital Guidance on Negotiating Consent Document Language For Clinical Trial Sponsors 1. Review and approval of the consent document is a responsibility that FDA
More informationIRBMED: Ceding IRB Review to an External IRB
: Ceding IRB Review to an External IRB Angela Faber, BS, CIP Senior Associate Regulatory Analyst, Seminar Series April 10, 2018 TERMINOLOGY For the purposes of this presentation: IRB of Record External
More informationAUTHORITY AND PURPOSE
AUTHORITY AND PURPOSE SOP #: 101 VERSION #: 1 THIS POLICY PERTAINS TO: RESPONSIBILITY FOR EXECUTING POLICY: EFFECTIVE DATE: 5/1/09 ALL ACTIVITIES OF THE IRB SUPERSEDES DOCUMENT: IRB STAFF, IRB CHAIRPERSON,
More informationCUNY HRPP Policy: Suspension or Termination of Human Subject Research
CUNY HRPP Policy: Suspension or Termination of Human Subject Research 1. Overview A UI- IRB or the Vice Chancellor for Research may suspend or terminate a research study for reasons including that: a)
More informationYale University Human Research Protection Program
Yale University Human Research Protection Program HRPP Policy 700 Noncompliance, Suspension and Termination Responsible Office Office of Research Administration Effective Date: February 10, 2009 Responsible
More informationCUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research
CUNY HRPP Procedures: Multisite Non-Exempt Human Subjects Research 1. Applicability These procedures apply to non-exempt multi-site research involving human subjects in which CUNY is engaged. Please refer
More informationEMERGENCY USE 03/02/2016
DUKE UNIVERSITY HEALTH SYSTEM Human Research Protection Program EMERGENCY USE 03/02/2016 Emergency Exemption for an Investigational Drug or Biologic or Unapproved Device Emergency use of an investigational
More informationEffective Date Revisions Date Review by the Convened Institutional Review Board
Review by the Convened Institutional Review Board Effective Date Revisions Date 8.1.2018 1.0 Purpose: The purpose of this standard operating practice (SOP) is to define and describe the process of review
More informationGuidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval
Guidance for IRBs, Clinical Investigators, and Sponsors IRB Continuing Review after Clinical Investigation Approval Additional copies are available from: Office of Communication Division of Drug Information,
More informationYour Roadmap to Single IRB Review Getting Started with SMART IRB & the Online Reliance System
Your Roadmap to Single IRB Review Getting Started with SMART IRB & the Online Reliance System Now that your institution has joined SMART IRB, what s next? Start using the Agreement right away for IRB reliance
More informationPolicy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013; 05/01/2016; 10/16/2018
University of California, Irvine Human Research Protections Standard Operating Policies and Procedures Policy Number: 42 Title: Investigational Devices Date of Last Revision: 06/12/2008; 07/22/2010; 05/29/2013;
More information